REVVITY, INC Finite-Lived Intangible Asset, Expected Amortization, Year One
REVVITY, INC (RVTY) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $312.90 million as of 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-11
- 2026-07-05: Finite-Lived Intangible Asset, Expected Amortization, Year One $312.90M.
- 2026-04-05: Finite-Lived Intangible Asset, Expected Amortization, Year One $312.70M.
- 2025-12-28: Finite-Lived Intangible Asset, Expected Amortization, Year One $332.20M.
- 2025-09-28: Finite-Lived Intangible Asset, Expected Amortization, Year One $332.10M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-07-05 | $312.90M 10-Q · filed 2026-08-11 |
| 2026-04-05 | $312.70M 10-Q · filed 2026-05-12 |
| 2025-12-28 | $332.20M 10-K · filed 2026-02-24 |
| 2025-09-28 | $332.10M 10-Q · filed 2025-11-04 |
| 2025-06-29 | $332.90M 10-Q · filed 2025-08-05 |
| 2025-03-30 | $327.80M 10-Q · filed 2025-05-06 |
| 2024-12-29 | $331.50M 10-K · filed 2025-02-25 |
| 2024-09-29 | $337.30M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $332.90M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $333.40M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $362.60M 10-K · filed 2024-02-27 |
| 2023-10-01 | $358.60M 10-Q · filed 2023-11-07 |
| 2023-07-02 | $357.10M 10-Q · filed 2023-08-09 |
| 2023-04-02 | $357.60M 10-Q · filed 2023-05-12 |
| 2023-01-01 | $363.80M 10-K · filed 2023-03-01 |
| 2022-10-02 | $356.60M 10-Q · filed 2022-11-14 |
| 2022-07-03 | $394.00M 10-Q · filed 2022-08-09 |
| 2022-04-03 | $402.40M 10-Q · filed 2022-05-10 |
| 2022-01-02 | $413.60M 10-K · filed 2022-03-03 |
| 2021-10-03 | $414.30M 10-Q · filed 2021-11-09 |
| 2021-07-04 | $224.20M 10-Q · filed 2021-08-10 |
| 2021-04-04 | $205.40M 10-Q · filed 2021-05-11 |
| 2021-01-03 | $211.00M 10-K · filed 2021-03-02 |
| 2020-10-04 | $180.20M 10-Q · filed 2020-11-10 |
| 2019-12-29 | $188.80M 10-K · filed 2020-02-25 |
| 2018-12-30 | $149.70M 10-K · filed 2019-02-26 |
| 2017-12-31 | $139.10M 10-K · filed 2018-02-27 |
| 2017-01-01 | $63.10M 10-K · filed 2017-02-28 |
| 2016-01-03 | $71.80M 10-K · filed 2016-03-01 |
| 2014-12-28 | $80.40M 10-K · filed 2015-02-24 |
| 2014-03-30 | $62.50M 10-Q · filed 2014-05-06 |
| 2013-12-29 | $83.20M 10-K · filed 2014-02-25 |
| 2013-09-29 | $21.90M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $44.50M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $66.70M 10-Q · filed 2013-05-06 |
| 2012-12-30 | $89.10M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |